Assessment of the potential ototoxicity of high-dose celecoxib, a selective cyclooxygenase-2 inhibitor, in rats

Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
Bei LiShan-Kai Yin

Abstract

To evaluate the potential ototoxicity of high-dose celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor. Prospective animal study. Laboratory. Twenty adult male Sprague Dawley rats were divided into 2 groups for hearing and tinnitus tests, respectively. The auditory brain-stem response (ABR) and the gap prepulse inhibition of acoustic startle (GPIAS) were used as indicators of hearing loss and tinnitus, respectively, and were measured before and at 2, 4, 6, 8, 12, 24, and 48 hours after administration of celecoxib (2 g/kg) via gavage. ABR threshold and wave III latencies did not increase significantly at any frequency following celecoxib administration, at any time point (P > .05). GPIAS remained below 30% after celecoxib, from a baseline of 20.03% ± 3.62%; no change was significant. High-dose celecoxib (2 g/kg), a selective COX-2 inhibitor, did not cause hearing loss or tinnitus in Sprague Dawley rats within 48 hours of administration. Further studies are needed to explore the roles played by COX-related mechanisms when nonselective COX inhibitors induce ototoxicity.

References

Jun 1, 1990·Hearing Research·P H Stypulkowski
Nov 18, 2005·Neuroscience Letters·Ulf-Rüdiger HeinrichWolf J Mann
Nov 7, 2006·International Journal of Pediatric Otorhinolaryngology·Jae-Gu ChoSung Won Chae
Aug 24, 2007·Audiology & Neuro-otology·Rosario Marchese-RagonaAlberto Staffieri
Nov 1, 2007·Journal of Basic and Clinical Physiology and Pharmacology·Uri PelegHaim Sohmer
Aug 30, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Louise S HarringtonJane A Mitchell
Nov 11, 2008·Biochemical and Biophysical Research Communications·Min Kyu ParkKi Churl Chang
Jan 22, 2009·Neuroscience·W SunR J Salvi
Mar 9, 2010·International Journal of Cardiology·Marie LordkipanidzéJean G Diodati
Oct 28, 2010·Clinical and Experimental Otorhinolaryngology·Gi Jung ImHak Hyun Jung
Jun 16, 2011·PloS One·Min Dai, Xiaorui Shi
Jul 26, 2011·The Journal of Laryngology and Otology·I de Almeida-SilvaM A Hyppolito
Oct 1, 2010·North American Journal of Medical Sciences·Ezekiel Uba Nwose, Nathan Cann
Feb 6, 2013·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Michael D SeidmanRobert T Standring
Mar 8, 2014·World Journal of Gastrointestinal Pharmacology and Therapeutics·Carlos SostresAngel Lanas
May 24, 2014·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·René H TolbaYuzo Yamamoto
Aug 30, 2014·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Feng-Ying ZhangXiu-Li Shang
Sep 13, 2014·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Fan HeHui-Sheng Chen

❮ Previous
Next ❯

Software Mentioned

Gpower
SPSS

Related Concepts

Related Feeds

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.

Related Papers

Acta otorhinolaryngologica Italica : organo ufficiale della Società italiana di otorinolaringologia e chirurgia cervico-facciale
Massimo RalliAnna Rita Fetoni
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
Massimo RalliRichard Salvi
Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
Hao XiongYiqing Zheng
Nihon rinsho. Japanese journal of clinical medicine
K NakaK Nanjo
© 2021 Meta ULC. All rights reserved